fbpx

VAI-SU2C Epigenetics Dream Team

31 results.

March 27, 2024 Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor types

GRAND RAPIDS, Mich. (March 27, 2024) — A pair of medications that make malignant cells act as if they have a virus could hold new promise for…

August 3, 2023 Making an impact in the real-world: Five things to know about the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team

Since October 2014, the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team has supported and launched breakthrough clinical trials that explore potential new…

November 1, 2022 Combining two cancer medications may increase survival in relapsed myelodysplastic syndrome, lays groundwork for future cancer therapies

GRAND RAPIDS, Mich. (Nov. 1, 2022) — A pair of cancer medications that act as a one-two punch against malignant cells demonstrated increased survival in…

December 14, 2021 A year — and a quarter century — in review

As 2021 comes to a close, so too does Van Andel Institute’s celebration of our 25th anniversary. The Institute’s story began with a vision: to…

October 18, 2019 How Van Andel Institute supports clinical trials through collaboration and connection

Institute serves as a connector that fosters discovery of potential new treatments Clinical trials can be a bastion of hope for people living with terminal…

May 6, 2019 Combating cancer from the lab to the clinic

May is Cancer Research Month, which raises awareness for the efforts underway to prevent, treat and, ultimately, cure cancer.

When it comes to…

April 4, 2019 Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer

GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called…

September 10, 2018 That’s a wrap! Van Andel Research Institute featured in Stand Up To Cancer telecast

Last Friday was a day to remember, one that will affect lives for years to come. We were thrilled to be a part of the